Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 27, 2019 08:30 ET | Source: Hemostemix Inc.

Hemostemix Announces Enrollment Update for the ACP-01 Phase II Critical Limb Ischemia Clinical Trial

CALGARY, Alberta, June 27, 2019 (GLOBE NEWSWIRE) -- Hemostemix Inc. (“Hemostemix” or the “Company”) (TSX VENTURE: HEM; OTCQB: HMTXF) is pleased to announce that it has enrolled a total of forty (40)...
April 15, 2019 08:30 ET | Source: Hemostemix Inc.

Hemostemix Announces Convertible Debenture Financing

NOT FOR DISTRIBTUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES CALGARY, Alberta, April 15, 2019 (GLOBE NEWSWIRE) -- Hemostemix Inc. (“Hemostemix” or the “Company”) (TSX...
April 09, 2019 08:30 ET | Source: Hemostemix Inc.

Hemostemix Announces Enrollment Milestone in the ACP-01 Phase II Critical Limb Ischemia Clinical Trial

CALGARY, Alberta, April 09, 2019 (GLOBE NEWSWIRE) -- Hemostemix Inc. (“Hemostemix” or the “Company”) (TSX VENTURE: HEM; OTCQB: HMTXF) is pleased to announce that it has reached an enrollment...
April 01, 2019 08:30 ET | Source: Hemostemix Inc.

Hemostemix Announces Appointment of Experienced Chief Medical Officer & President

CALGARY, Alberta, April 01, 2019 (GLOBE NEWSWIRE) -- Hemostemix Inc. (“Hemostemix” or the “Company”) (TSX VENTURE: HEM; OTCQB: HMTXF) is pleased to announce that Dr. Alan J. Jacobs, M.S.EE, M.D,...
February 25, 2019 08:30 ET | Source: Hemostemix Inc.

Hemostemix Announces UC Davis Health Added as a Trial Site for Phase II Clinical Trial

CALGARY, Alberta, Feb. 25, 2019 (GLOBE NEWSWIRE) -- Hemostemix Inc. (“Hemostemix” or the “Company”) (TSX VENTURE: HEM; OTCQB:HMTXF) is pleased to announce that it has received all approvals from UC...
February 04, 2019 08:30 ET | Source: Hemostemix Inc.

Hemostemix Announces Submission of Orphan Drug Designation Application to the FDA

CALGARY, Alberta, Feb. 04, 2019 (GLOBE NEWSWIRE) -- Hemostemix Inc. (“Hemostemix” or the “Company”) (TSX VENTURE: HEM; OTCQB: HMTXF) a biotechnology company focused on developing and commercializing...
January 29, 2019 11:13 ET | Source: GL Communications Inc.

PacketExpert™ APIs for Test Automation and Remote Access

GAITHERSBURG, Md., Jan. 29, 2019 (GLOBE NEWSWIRE) -- GL Communications Inc. a global leader in telecom test and measurement solutions, announced today its Test Automation and Remote Testing through...
January 17, 2019 08:30 ET | Source: Hemostemix Inc.

Hemostemix Provides Highlights of 2018 Accomplishments

CALGARY, Alberta, Jan. 17, 2019 (GLOBE NEWSWIRE) -- Hemostemix Inc. (“Hemostemix” or the “Company”) (TSX VENTURE: HEM; OTCQB: HMTXF) is pleased to provide the following corporate update on...
January 03, 2019 08:00 ET | Source: Hemostemix Inc.

Hemostemix Announces Two Additional Sites Enrolled in Phase II Clinical Trial

CALGARY, Alberta, Jan. 03, 2019 (GLOBE NEWSWIRE) -- Hemostemix Inc. (“Hemostemix” or the “Company”) (TSX VENTURE: HEM; OTCQB:HMTXF) is pleased to announce that it has received all approvals from two...
November 09, 2018 08:30 ET | Source: Hemostemix Inc.

Hemostemix Announces Development of an ACP-01 Allogeneic Process and Initiation of R&D for Autologous NCP-01 Neural Cellular Precursors

CALGARY, Alberta, Nov. 09, 2018 (GLOBE NEWSWIRE) -- Hemostemix Inc. (“Hemostemix” or the “Company”) (TSX VENTURE: HEM; OTCQB: HMTXF) is pleased to provide the following update on its research and...